|
Suppliers for CAS
162520-00-5
|
Properties | | CAS |
162520-00-5 | | Formula |
C22H30O2S |
|
|
5 Registered suppliers
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C22H30O2S
Molecular Weight: 358.54
Aea.ltd
P.R.China
Molecular Formula: C22H30O2S
Molecular Weight: 358.54
BOC Sciences
USA
Description : Salirasib is a salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, thereby preventing activation of RAS signaling cascades that mediated cell proliferation, differentiation, and senescence. RAS signaling is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Molecular Formula : C22H30O2S Canonical SMILES : CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C InChI : InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+
InChIKey :
WUILNKCFCLNXOK-CFBAGHHKSA-N
Synonyms :
Salirasib; Farnesylthiosalicylic acid; S-Farnesylthiosalicylic acid; FTS.
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Salirasib is a salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, thereby preventing activation of RAS signaling cascades that mediated cell proliferation, differentiation, and senescence. RAS signaling is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Molecular Formula : C22H30O2S Canonical SMILES : CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C InChI : InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+
InChIKey :
WUILNKCFCLNXOK-CFBAGHHKSA-N
Synonyms :
Salirasib; Farnesylthiosalicylic acid; S-Farnesylthiosalicylic acid; FTS.
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Salirasib is a salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, thereby preventing activation of RAS signaling cascades that mediated cell proliferation, differentiation, and senescence. RAS signaling is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Molecular Formula : C22H30O2S Canonical SMILES : CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C InChI : InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+
InChIKey :
WUILNKCFCLNXOK-CFBAGHHKSA-N
Synonyms :
Salirasib; Farnesylthiosalicylic acid; S-Farnesylthiosalicylic acid; FTS.
More details are to be found here
|
details
details